Cited by 43Cardiac pacing and defibrillation studiesHeart Failure Treatment and ManagementCardiac Arrest and Resuscitation

Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure

Hoppe, Uta C., Freemantle, Nick, Cleland, John G.F., Marijianowski, Monique, Erdmann, Erland·2007·Diabetes Care

Abstract

Diabetes is a well-known and important risk factor for heart disease, including heart failure (1–4). Despite improvements in pharmacologic treatment, many patients with heart failure have severe and persistent symptoms, and their prognosis remains poor (5,6). While most recent data indicate a higher mortality rate in diabetic patients with heart failure compared with nondiabetic patients (7–9), it is unresolved whether this effect might be limited to patients with ischemic heart disease and/or patients on insulin therapy (10–13). Cardiac resynchronization therapy (CRT) reduces symptoms and improves left ventricular function and prognosis in many patients with moderate-to-severe heart failure due to systolic dysfunction and cardiac dyssynchrony (14–19). The pathophysiology underlying heart failure in diabetic patients differs from that in nondiabetic patients and is generally considered more progressive. Thus, direct and indirect effects of diabetes on myopathic mechanisms might influence the response of heart failure patients to CRT. We conducted an analysis of the 813 participants of the Cardiac Resynchronisation in Heart Failure (CARE-HF) trial to determine the effect of CRT on the risk of complications and death in diabetic compared with nondiabetic heart failure patients. We also tested the hypothesis that diabetes has a prognostic impact in patients with heart failure. The CARE-HF trial (14,20–22) investigated the effects of cardiac resynchronization on morbidity and mortality in patients receiving standard pharmacologic therapy …

Integrity signals

Registry

Crossref · 10.2337/dc06-2035

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hoppe, U. C., Freemantle, N., Cleland, J. G. F., Marijianowski, M., & Erdmann, E.
Affiliations
  • University of Cologne (DE)
  • University of Birmingham (GB)
  • Castle Hill Hospital (GB)
  • Medtronic (Netherlands) (NL)
Venue
Diabetes Care
Published
2007-03-01
Volume
30
Issue
3
Pages
722-724
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2098198487
Cited by
43
References
31
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 4 · 2017: 1 · 2016: 4 · 2015: 5 · 2014: 2 · 2013: 1 · 2012: 4
FWCI
2.57
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Keywords
cardiac resynchronization therapy, diabetic heart failure, diabetes mellitus, heart failure prognosis, mortality, morbidity, insulin therapy, ischemic heart disease, CARE-HF trial, cardiac dyssynchrony, left ventricular function
MeSH terms
Cardiac Pacing, Artificial, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Heart Failure, Humans, Prognosis, Survival Analysis, Treatment Outcome, Myocardial Ischemia, Ventricular Dysfunction, Left

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review